IL6 and asthma: Blood biomarkers including C-reactive protein, IL-6, and fibrinogen can detect a systemic inflammatory component of COPD, important in predicting patients at risk of exacerbations [27], but these markers are not specific to COPD and have been determined to be elevated in the neutrophilic asthma phenotype [28].